Clinical Trials Directory

Trials / Completed

CompletedNCT01528605

Effects of Lutein and Zeaxanthin Supplementation on Early Age-related Macular Degeneration

The Effects of Lutein and Zeaxanthin Supplementations on Early Age-related Macular Degeneration

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
168 (actual)
Sponsor
Peking University · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

This study is to investigate the protective effects of supplemental lutein and zeaxanthin on early age-related macular degeneration (AMD) patients in China.

Detailed description

Early age-related macular degeneration (AMD) is an early hallmark of irreversible vision impairment accompanying with senescence of macular. Given the fact in treatment, prevention strategy is thought to be an efficient and robust approach to diminish early AMD patients in low-income countries, however, feasible cocktail provision in most developing nations remain mysteries. Here we proposed an effective cocktail treatment with different amounts of lutein and zeaxanthin could increase the macular pigment optical density (MPOD) and serum xanthophylls concentrations among randomized Chinese AMD patients; and might improve visual function measured by visual performance indices such as best-spectacle corrected visual acuity (BSCVA), contrast sensitivity (CSF), flash recovery time (FRT), multifocal electroretinogram (mfERG) and microperimetry.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTplaceboPlacebo, one gelatine capsule containing starch per day, for 96 weeks
DIETARY_SUPPLEMENTlow luteinone gelatine capsule containing 10mg lutein per day, for 96 weeks
DIETARY_SUPPLEMENThigh luteinone gelatine capsule containing 20mg lutein per day, for 96 weeks
DIETARY_SUPPLEMENTlutein plus zeaxanthinone gelatine capsule containing 10mg lutein and 10mg zeaxanthin per day, for 96 weeks
DIETARY_SUPPLEMENThigh zeaxanthinone gelatine capsule containing 10mg zeaxanthin per day, for 48 weeks
DIETARY_SUPPLEMENTzeaxanthin plus luteinone gelatine capsule containing 10 mg lutein and 15 mg zeaxanthin per day, for 48 weeks

Timeline

Start date
2010-06-01
Primary completion
2012-09-01
Completion
2012-12-01
First posted
2012-02-08
Last updated
2014-08-29
Results posted
2014-08-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01528605. Inclusion in this directory is not an endorsement.